User profiles for Elisabetta Renzoni

Elisabetta Renzoni

ILD Consultant, Royal Brompton Hospital
Verified email at rbht.nhs.uk
Cited by 14988

Diagnosis of hypersensitivity pneumonitis in adults: an official ATS/JRS/ALAT clinical practice guideline

…, S Patolia, CA Pereira, EA Renzoni… - American journal of …, 2020 - atsjournals.org
Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It
represents a collaborative effort among the American Thoracic Society, Japanese …

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the …

…, CP Denton, M Eastwood, EA Renzoni… - Molecular biology of …, 2004 - Am Soc Cell Biol
The endothelins are a family of endothelium-derived peptides that possess a variety of functions,
including vasoconstriction. Endothelin-1 (ET-1) is up-regulated during tissue repair and …

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

…, FJ Martinez, PL Molyneaux, EA Renzoni… - The lancet Respiratory …, 2020 - thelancet.com
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who
have inexorable progression of pulmonary fibrosis despite treatment, which is known as the …

Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes

…, A Rice, TM Maher, EA Renzoni… - European …, 2012 - Eur Respiratory Soc
Pleuroparenchymal fibroelastosis (PPFE) is a rare condition characterised by predominantly
upper lobe pleural and subjacent parenchymal fibrosis, the latter being intra-alveolar with …

Road traffic and adverse respiratory effects in children. SIDRIA Collaborative Group.

…, TF Volante, C Galassi, S Piffer, E Renzoni… - Occupational and …, 1998 - oem.bmj.com
OBJECTIVES: To investigate the relation between traffic indicators in the area of residence
and the occurrence of chronic respiratory disorders in children. METHODS: A population …

Rituximab in severe, treatment‐refractory interstitial lung disease

…, DM Hansell, AU Wells, EA Renzoni - …, 2014 - Wiley Online Library
Background and objective In patients with severe interstitial lung disease ( ILD ) progressing
despite conventional immunosuppression, rituximab, a B ‐lymphocyte depleting …

Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline

…, K Lindell, V Prieto-Centurion, EA Renzoni… - American journal of …, 2020 - atsjournals.org
Background: Evidence-based guidelines are needed for effective delivery of home oxygen
therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and …

Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study

…, H Parfrey, V Poletti, JC Porter, E Renzoni… - American journal of …, 2020 - atsjournals.org
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Short‐term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis

…, CP Denton, DM Hansell, EA Renzoni… - Arthritis & …, 2017 - Wiley Online Library
Objective To determine the prognostic value of pulmonary function test (PFT) trends at 1 and
2 years in interstitial lung disease (ILD) associated with systemic sclerosis (SSc). Methods …

Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis

…, P Kelleher, L Hector, AU Wells, EA Renzoni - The Journal of …, 2013 - jrheum.org
Objective. Biomarkers of progression of interstitial lung disease (ILD) are needed to allow
early therapeutic intervention in patients with scleroderma-associated disease (SSc-ILD). …